Literature DB >> 21136708

Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ™ isobaric tags.

Mia Jüllig1, Anthony J Hickey, Martin J Middleditch, David J Crossman, Stanley C Lee, Garth J S Cooper.   

Abstract

Diabetes now affects more than 5% of the world's population and heart failure is the most common cause of death amongst diabetic patients. Accumulating evidence supports a view that myocardial mitochondrial structural and functional changes are central to the onset of diabetic heart failure, but the exact nature of these changes at the proteomic level remains unclear.Here we report on proteomic changes in diabetic rat heart mitochondria following 120 days of streptozotocin-diabetes using the recently developed iTRAQ™ labeling method, which permits quantification of proteins directly from complex mixtures, bypassing the limitations associated with gel-based methods such as 2-DE. Of 252 unique proteins identified, 144 were represented in at least three of six individual paired experiments. Relative amounts of 65 proteins differed significantly between the groups, confirming that the cardiac mitochondrial proteome is indeed impacted by diabetes. The most significant changes were increased protein levels of enzymes involved in mitochondrial oxidation of long-chain fatty acids, which was also confirmed by enzyme assays, and decreased levels of multiple enzymes involved in oxidative phosphorylation and catabolism of short-chain fatty acids and branched-chain amino acids. We also found significant changes in levels of several enzymes linked to oxidative stress.
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2007        PMID: 21136708     DOI: 10.1002/prca.200600831

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  18 in total

1.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

2.  Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases.

Authors:  Ziyou Cui; Shannamar Dewey; Aldrin V Gomes
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

3.  Early organ-specific mitochondrial dysfunction of jejunum and lung found in rats with experimental acute pancreatitis.

Authors:  Anubhav Mittal; Anthony J R Hickey; Chau C Chai; Benjamin P T Loveday; Nichola Thompson; Anna Dare; Brett Delahunt; Garth J S Cooper; John A Windsor; Anthony R J Phillips
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

4.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

Review 5.  Mechanisms underlying the impaired contractility of diabetic cardiomyopathy.

Authors:  Marie-Louise Ward; David J Crossman
Journal:  World J Cardiol       Date:  2014-07-26

Review 6.  Proteomic remodeling of mitochondria in heart failure.

Authors:  John M Hollander; Walter A Baseler; Erinne R Dabkowski
Journal:  Congest Heart Fail       Date:  2011-10-03

Review 7.  Quantitative proteomics in cardiovascular research: global and targeted strategies.

Authors:  Xiaomeng Shen; Rebeccah Young; John M Canty; Jun Qu
Journal:  Proteomics Clin Appl       Date:  2014-07-14       Impact factor: 3.494

Review 8.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 9.  Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.

Authors:  Gregory Aubert; Rick B Vega; Daniel P Kelly
Journal:  Biochim Biophys Acta       Date:  2012-08-31

10.  Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase.

Authors:  Walter A Baseler; Erinne R Dabkowski; Rajaganapathi Jagannathan; Dharendra Thapa; Cody E Nichols; Danielle L Shepherd; Tara L Croston; Matthew Powell; Trust T Razunguzwa; Sara E Lewis; David M Schnell; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.